Eye Diseases > Eyelids
Eyelid Papilloma
Clinical reference for common benign eyelid papilloma, including recognition, risk assessment, treatment choices, and practical differentiation from eyelid malignancies.
Figure: Right panel demonstrates common eyelid papilloma morphology at the upper lid margin. Most are benign and treated for irritation or cosmesis, but suspicious lesions require histopathologic confirmation.
Eyelid papilloma is one of the most common benign eyelid tumours encountered in primary eye care. It arises from localised overgrowth of surface epithelium and can present as a pedunculated, filiform, or sessile lesion on the eyelid skin or margin. While the vast majority are entirely benign, their clinical significance lies in reliably distinguishing them from malignant masquerade lesions — particularly basal cell carcinoma, squamous cell carcinoma, and sebaceous carcinoma.
Most cases require no treatment beyond reassurance and photographic monitoring. Intervention is indicated for symptomatic, rapidly growing, or atypical lesions. In Singapore, optometrists play a key role in identifying and appropriately triaging these lesions, referring for histopathological confirmation when any feature is suspicious.
Etiology
Benign Epithelial Proliferation
The most common mechanism in acquired eyelid papilloma. Localised overgrowth of stratified squamous epithelium occurs without a clear viral cause, typically associated with ageing skin changes and chronic mild trauma or friction. The result is a benign, slow-growing exophytic lesion arising from the epidermal surface of the eyelid.
HPV-Associated Variants
A subset of eyelid papillomas, particularly those with a verrucous morphology, are associated with low-risk human papillomavirus types — most commonly HPV 6 and HPV 11. These are the same subtypes responsible for anogenital condylomata and recurrent respiratory papillomatosis. Viral-mediated lesions tend to occur in younger patients, immunosuppressed individuals, and those with a personal or household history of cutaneous warts.
Other Contributing Factors
- Chronic irritation or friction: recurrent eyelid rubbing or contact may serve as a localised proliferative stimulus.
- UV exposure: a possible co-factor in periocular epithelial lesion development, particularly for lesions on sun-exposed skin.
- Age-related epithelial changes: increased incidence in middle-aged and older adults mirrors the general rise in benign skin lesions with age.
Pathogenesis
- Initiating trigger: epithelial mutation, cytokine-mediated irritation, or viral-mediated proliferative signalling activates keratinocyte hyperplasia.
- Keratinocyte hyperplasia: localised overgrowth of stratified squamous epithelium forms an exophytic mass with acanthosis and papillomatosis.
- Papillary architecture development: a fibrovascular core develops, supporting the overlying acanthotic epithelium and giving the characteristic papillary (frond-like) morphology on histology.
- Morphologic maturation: the lesion progressively becomes either pedunculated (narrow stalk attachment) or sessile (broad base), growing slowly over months to years.
- Clinical stability: most lesions remain indolent and self-limiting. Symptomatic presentations arise when the lesion traumatises the ocular surface, causes friction with each blink, or bleeds after minor contact.
Classification
By Morphology
- Pedunculated (filiform): exophytic lesion attached by a narrow stalk; can swing freely and cause mechanical ocular surface irritation.
- Sessile: broad-based lesion with flatter attachment to the eyelid skin; less likely to cause mechanical symptoms.
- Verrucous: rough, papilliform surface suggestive of HPV-related wart-like pattern; may be more adherent to surrounding skin.
By Location
- Lid skin (most common): upper or lower eyelid skin surface; usually well away from the lid margin.
- Lid margin / perilash area: higher clinical significance due to mechanical corneal contact with each blink; requires prompt evaluation.
- Canthal / pericanthal skin: medial or lateral canthus; cosmetically conspicuous but usually straightforward to monitor or excise.
By Clinical Behaviour
- Clinically benign and stable: classic appearance, no growth, no symptoms — suitable for observation with photography.
- Irritative / recurrently traumatised: symptomatic removal is appropriate even without malignant features.
- Atypical or suspicious: any feature inconsistent with benign papilloma mandates biopsy and histopathological exclusion of malignancy.
Risk Factors
- Increasing age: the most consistent risk factor; benign epithelial proliferation becomes more frequent with each decade.
- History of cutaneous viral warts: for HPV-related variants, a personal or household history of verruca vulgaris or anogenital warts increases risk.
- Chronic eyelid rubbing or local irritation: repeated mechanical trauma or allergic eye disease may serve as a proliferative stimulus.
- High cumulative UV exposure: periocular skin is susceptible to UV-induced epithelial changes, especially in outdoor workers.
- Immunosuppression: organ transplant recipients and patients on chronic immunosuppressive therapy have a significantly higher burden of HPV-related epithelial lesions and greater difficulty eradicating them.
- Personal history of multiple benign skin lesions: seborrhoeic keratoses, skin tags, and fibromas often coexist with eyelid papilloma in the same patient.
Clinical Signs
- Localised flesh-coloured, tan, or lightly pigmented eyelid lesion.
- Smooth, lobulated, or verrucous surface depending on subtype.
- Pedunculated or sessile attachment to the eyelid skin or margin.
- Slow, gradual enlargement over months to years.
- Well-circumscribed margins without ulceration or induration in classic benign cases.
- Single or, less commonly, multiple lesions on the same or adjacent eyelid.
Symptoms
- Often completely asymptomatic — most patients present after noticing the lesion in a mirror or having it pointed out by someone else.
- Cosmetic concern is the commonest presenting complaint, especially for prominent or margin-based lesions.
- Occasional foreign-body sensation when the lesion rubs against the ocular surface or adjacent eyelid skin.
- Intermittent irritation with blinking if the lesion is near the lash line or lid margin.
- Rare mild pain or tenderness when the lesion is traumatised (caught on clothing, rubbed) or undergoes secondary inflammation.
- Epiphora (tearing) if the lesion distorts the punctum or lower lid margin.
Complications
- Recurrent irritation or rubbing-related inflammation when lesion is near the lid margin or lash line.
- Mechanical corneal punctate epithelial erosions (PEE) from repeated contact of a pedunculated margin lesion with the corneal surface.
- Bleeding after minor trauma in exophytic lesions with a rich vascular stalk.
- Cosmetic distress and quality-of-life impact, particularly in younger or professionally active patients.
- Procedure-related complications (pigment change, scar, recurrence) — usually mild with proper technique and specialist management.
- Most clinically important risk: delayed or missed diagnosis when a malignant eyelid lesion (BCC, SCC, sebaceous carcinoma) is mistaken for a benign papilloma and treated without histopathological confirmation.
Systemic Relations
Most eyelid papillomas are localised benign lesions with no direct systemic complications. Systemic relevance arises primarily in contexts of increased epithelial lesion burden or underlying immunological dysfunction.
- HPV-related disease burden: eyelid papilloma may coexist with cutaneous or mucosal papillomatous lesions elsewhere in the body (skin warts, condylomata). A thorough skin and systemic history is warranted in patients with multiple or recurrent lesions.
- Immunosuppression: post-transplant patients, HIV-positive individuals, and those on chronic immunosuppressive medications have a significantly higher prevalence and recurrence rate of HPV-related eyelid lesions.
- Rare syndromic associations: epidermodysplasia verruciformis (a rare genodermatosis causing widespread HPV-related skin lesions with high malignant transformation risk) and other genetic skin disorders may include periocular papillomatous lesions.
Diagnosis
Clinical Assessment
Diagnosis is primarily clinical, based on lesion morphology and behaviour over time. A structured assessment approach is essential to identify any features of malignant masquerade.
- Focused history: duration, growth rate, bleeding, ulceration, recurrence, prior treatments, immune status.
- Slit-lamp or magnified external exam: base, colour, surface texture, vascularity, lash margin involvement.
- Photo documentation for serial comparison — essential for monitoring decisions.
- Biopsy or excision histopathology for atypical, recurrent, rapidly growing, or suspicious lesions.
Imaging Findings
- Dermoscopy: finger-like projections with hairpin or dotted vessels at the tips; exophytic papillary surface; absence of pigment network distinguishes from melanocytic lesions.
- Slit-lamp with high magnification: confirms vascular pattern at the lesion tip, rules out lid margin involvement, and excludes concurrent conjunctival papilloma (different HPV subtypes, different management).
Clinical Classification by Action
| Type | Features | Action |
|---|---|---|
| Filiform | Pedunculated, single, narrow stalk, classic morphology | Observe or elective removal |
| Sessile | Broad-based, single lesion, slow or no growth | Observe or elective removal |
| Multiple | HPV-associated or immunosuppression context | Assess immune status; HPV typing optional; refer |
| Atypical | Ulceration, irregular vessels, rapid growth, bleeding, lash loss | Urgent biopsy to exclude SCC/BCC |
Management
Singapore Optometry Scope Note: Optometrists are able to identify and monitor stable eyelid papillomas. Excision, biopsy, or any procedural removal requires ophthalmology or oculoplastic referral. Any lesion showing growth, irregular features, suspected malignancy, or diagnostic uncertainty should be referred promptly for histopathological evaluation.
Conservative Management
- Observation with serial photography for classic benign, asymptomatic, stable lesions.
- Patient education regarding red-flag changes (rapid growth, ulceration, bleeding, lash loss) and appropriate review interval (typically 6–12 months for stable lesions).
- No topical treatment is established as effective for eyelid papilloma; imiquimod is occasionally used for extensive HPV-related lesions under specialist guidance.
Procedural Options (Ophthalmology / Oculoplastics)
- Shave or snip excision: the most common office-based approach for pedunculated or filiform lesions.
- Excisional biopsy: preferred when diagnosis is uncertain, the lesion is growing, or any feature is suspicious — provides tissue for histopathology.
- Cryotherapy: selected cases, particularly HPV-related verrucous lesions; risk of hypopigmentation on facial skin.
- Electrocautery / radiofrequency ablation: useful for base obliteration after shave excision to reduce recurrence risk.
- Laser ablation (CO2 or Er:YAG): option in selected superficial lesions, particularly in cosmetically sensitive areas.
Post-Procedure Care
- Topical antibiotic ointment and wound hygiene instructions.
- Short follow-up to review healing and histopathology results.
- Further oculoplastic or oncology referral if histology reveals non-benign pathology.
Management Selection Guide
| Presentation | Recommended Approach | Optometry Role |
|---|---|---|
| Asymptomatic, stable, classic | Observation with photos | Monitor; 6–12 monthly review |
| Symptomatic (FBS, irritation) | Refer for elective removal | Refer to ophthalmology |
| Growing or multiple lesions | Excision + histopathology; immune assessment | Prompt referral |
| Atypical / red flags present | Urgent excisional biopsy | Urgent ophthalmology referral |
| Post-treatment recurrence | Re-excision with histology; consider wider margins | Refer; document carefully |
Prognosis
- Stable, asymptomatic lesions can be safely observed indefinitely with no meaningful risk of malignant change.
- Complete excision is highly curative; recurrence risk is low when the base is adequately treated.
- HPV-related variants have a higher recurrence rate; immunosuppressed patients may develop additional lesions over time.
- Cosmetic outcomes are generally very good when lid-margin-sparing technique is used by an experienced oculoplastic surgeon.
- Prognosis is fundamentally altered if a malignant lesion (BCC, SCC, sebaceous carcinoma) is identified on histology — underscoring the importance of biopsy for any atypical lesion.
Differential Diagnosis
Seborrhoeic keratosis
Waxy "stuck-on" plaque; often pigmented; greasy surface with keratin plugs; common in older adults.
Verruca vulgaris
Hyperkeratotic wart with rough papilliform surface; HPV 1/2/4; dermoscopy shows red dots at papillary tips.
Intradermal naevus
Dome-shaped, skin-coloured lesion; often with terminal hairs; smooth or polypoid surface.
Molluscum contagiosum
Umbilicated papule with central dell; often multiple; common in children and immunosuppressed adults; self-limiting.
Hydrocystoma
Translucent cystic lesion near lid margin; fluid-filled on transillumination; either apocrine or eccrine origin.
Pyogenic granuloma
Friable, vascular red lesion that bleeds easily; rapid onset often after minor trauma or lid surgery.
Basal cell carcinoma (BCC)
Pearly borders, telangiectasia, central ulceration (rodent ulcer), lash loss; most common eyelid malignancy — must not be missed.
Squamous cell carcinoma (SCC)
Keratinising plaque or nodule with induration, surface crusting; may arise de novo or from actinic keratosis.
Sebaceous gland carcinoma
Masquerades as recurrent chalazion; diffuse lid thickening; madarosis; pagetoid spread to conjunctiva; often misdiagnosed.
Comparison: Benign vs Malignant Eyelid Lesion Features
| Feature | Benign Papilloma | Malignant Masquerade |
|---|---|---|
| Growth rate | Slow (months–years) | Rapid or progressive |
| Lash involvement | Lashes intact | Lash loss (madarosis) |
| Surface | Intact, no ulceration | Ulceration, crusting, bleeding |
| Vascularity | Regular vascular pattern | Irregular telangiectasia |
| Recurrence | Low after complete removal | Frequent after incomplete excision |
Clinical Pearls
Any ulcerating papilloma requires urgent biopsy to exclude squamous cell carcinoma. SCC can present as a friable, ulcerating nodule that is clinically indistinguishable from an inflamed or traumatised papilloma, and delayed diagnosis has significant consequences.
Stable sessile papillomas that are asymptomatic and show no growth can be safely observed — reserve intervention for symptomatic, rapidly growing, or atypical lesions to avoid unnecessary procedures and associated risks.
Multiple papillomas in adults should prompt review of immunosuppression status and consideration of HPV-related aetiology, especially in post-transplant patients where HPV-related epithelial lesions are significantly more common and more difficult to eradicate.
Eyelid verruca vulgaris vs conjunctival papilloma: these are caused by different HPV subtypes (verruca = HPV 1/2/4; conjunctival papilloma = HPV 6/11) and have different management pathways. Conjunctival papilloma requires specialist management to prevent ocular surface seeding and recurrence.
Filiform papillomas near the lid margin can cause corneal punctate epithelial erosions (PEE) from mechanical rubbing with each blink. Symptomatic removal is appropriate regardless of lesion size, as even small lesions in this location cause significant ocular surface morbidity.
Singapore Optometry Scope Note: Refer atypical or rapidly growing lesions for histological confirmation — no in-clinic removal or cryotherapy. Document lesion size, location, and vascular pattern with close-up photography at every visit. Stable classic papillomas may be monitored with photographic documentation and 6-monthly review, with a low threshold for referral if any change occurs.
References
- American Academy of Ophthalmology. Basic and Clinical Science Course, Section 7: Orbit, Eyelids, and Lacrimal System. San Francisco: AAO; 2023–2024.
- Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Benign and malignant eyelid tumours: clinicopathologic analysis and management principles. Ophthalmic Plast Reconstr Surg. 2004.
- Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors: a retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009;31(3):256-262.
- Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746-750.
- Kersten RC, Ewing-Chow D, Kulwin DR, Gallon M. Accuracy of clinical diagnosis of cutaneous eyelid lesions. Ophthalmology. 1997;104(3):479-484.
- Grossniklaus HE, Green WR, Luckenbach M, Chan CC. Conjunctival lesions in adults: a clinical and histopathologic review. Cornea. 1987;6(2):78-116.
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27.
- Nemet AY, Deckel Y, Martin PA, et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol. 2006;142(2):293-296.
- British Oculoplastic Surgery Society. Guidelines for the management of periocular skin tumours. BOPSS Position Statement. 2022.
- Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology. 2003;110(10):2011-2018.
- Cameron JD, Bartley GB. Eyelid margin tumors and masquerade lesions: diagnostic pearls for eye-care clinicians. Surv Ophthalmol. 2002.
- UpToDate. Benign eyelid lesions and evaluation of suspicious eyelid tumors. Accessed March 2026.